Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose-derived MSC Therapy for Female Sexual Dysfunction in Women Aged 40-50
NCT06726538Phase 2Completed
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Start
- Oct 2023
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in female sexual dysfunction (FSD), sponsored by Vinmec Research Institute of Stem Cell and Gene Technology. Started Oct 2023; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NCT06726538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06726538.